|
|
|
By Rachel Grabenhofer, Chief Editor, Clinical Supply Leader | Many clinical supply challenges arise not from gaps in protocol information, but from operational implications recognized too late to influence decisions, as experts explain here. | |
|
|
|
By Angeliki Kotsianti, MD, Ph.D. | Clinical trial comparator sourcing can affect patient treatment and study design. Learn when comparator changes become clinical decisions and who should own them. | |
|
|
|
By Eshaan Jain | Small changes to IRT, EDC, and CTMS systems can quietly break validation. See why change control, testing, and documented approvals matter before deployment in a trial. | |
|
|
|
|
|
|
|
|
|